Ix Joachim H, Wassel Christina L, Bauer Douglas C, Toroian Damon, Tylavsky Frances A, Cauley Jane A, Harris Tamara B, Price Paul A, Cummings Steven R, Shlipak Michael G
Division of Nephrology, Department of Medicine, University of California San Diego, San Diego, California, USA.
J Bone Miner Res. 2009 Mar;24(3):514-21. doi: 10.1359/jbmr.081017.
Fetuin-A is a hepatic secretory protein that promotes bone mineralization in vitro. Whether fetuin-A levels are associated with BMD in humans is unknown. The Health Aging and Body Composition study enrolled 3075 well-functioning black and white persons 70-79 yr of age and measured BMD. This cross-sectional study measured serum fetuin-A using ELISA among a random sample of 508 participants within sex and race strata. Multivariate linear regression analysis evaluated the associations of fetuin-A with BMD. Among women (n = 257), higher fetuin-A levels were significantly associated with higher total hip (p = 0.02), lumbar spine (p = 0.03), and whole body BMD (p = 0.01) in models adjusted for age, race, diabetes, alcohol and tobacco use, physical activity, body mass index, C-reactive protein levels, calcium supplement, and estrogen use. For example, each SD (0.38 g/liter) higher level of fetuin-A was associated with 0.016 g/cm(2) higher total hip areal BMD. The association was of similar magnitude and direction for femoral neck BMD but did not reach statistical significance (p = 0.11). In contrast, among men (n = 251), fetuin-A had no significant associations with total hip (p = 0.79), lumbar spine (p = 0.35), whole body (p = 0.46), or femoral neck BMD (p = 0.54) in multivariable models. We conclude that higher fetuin-A levels are independently associated with higher BMD among well-functioning community-dwelling older women but not older men. Future studies should evaluate whether fetuin-A may refine fracture risk assessment in older women.
胎球蛋白-A是一种肝脏分泌蛋白,在体外可促进骨矿化。胎球蛋白-A水平与人类骨密度(BMD)是否相关尚不清楚。健康老龄化与身体成分研究招募了3075名70 - 79岁功能良好的黑人和白人,并测量了他们的骨密度。这项横断面研究在按性别和种族分层的508名参与者的随机样本中,使用酶联免疫吸附测定法(ELISA)测量血清胎球蛋白-A。多变量线性回归分析评估了胎球蛋白-A与骨密度的关联。在女性(n = 257)中,在调整了年龄、种族、糖尿病、饮酒和吸烟情况、身体活动、体重指数、C反应蛋白水平、钙补充剂和雌激素使用情况的模型中,较高的胎球蛋白-A水平与较高的全髋部(p = 0.02)、腰椎(p = 0.03)和全身骨密度(p = 0.01)显著相关。例如,胎球蛋白-A每升高1个标准差(0.38克/升),全髋部面积骨密度就会升高0.016克/平方厘米。股骨颈骨密度的关联程度和方向相似,但未达到统计学显著性(p = 0.11)。相比之下,在男性(n = 251)中,在多变量模型中,胎球蛋白-A与全髋部(p = 0.79)、腰椎(p = 0.35)、全身(p = 0.46)或股骨颈骨密度(p = 0.54)均无显著关联。我们得出结论,在功能良好的社区居住老年女性中,较高水平的胎球蛋白-A与较高的骨密度独立相关,但在老年男性中并非如此。未来的研究应评估胎球蛋白-A是否可改善老年女性骨折风险评估。